206 related articles for article (PubMed ID: 29596642)
1. The DNA damage response activates HPV16 late gene expression at the level of RNA processing.
Nilsson K; Wu C; Kajitani N; Yu H; Tsimtsirakis E; Gong L; Winquist EB; Glahder J; Ekblad L; Wennerberg J; Schwartz S
Nucleic Acids Res; 2018 Jun; 46(10):5029-5049. PubMed ID: 29596642
[TBL] [Abstract][Full Text] [Related]
2. hnRNP L controls HPV16 RNA polyadenylation and splicing in an Akt kinase-dependent manner.
Kajitani N; Glahder J; Wu C; Yu H; Nilsson K; Schwartz S
Nucleic Acids Res; 2017 Sep; 45(16):9654-9678. PubMed ID: 28934469
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneous Nuclear Ribonucleoprotein C Proteins Interact with the Human Papillomavirus Type 16 (HPV16) Early 3'-Untranslated Region and Alleviate Suppression of HPV16 Late L1 mRNA Splicing.
Dhanjal S; Kajitani N; Glahder J; Mossberg AK; Johansson C; Schwartz S
J Biol Chem; 2015 May; 290(21):13354-71. PubMed ID: 25878250
[TBL] [Abstract][Full Text] [Related]
4. Adenosine causes read-through into the late region of the HPV16 genome in a guanosine-dependent manner.
Yu H; Wu C; Nilsson K; Kajitani N; Schwartz S
Virology; 2018 Aug; 521():1-19. PubMed ID: 29864673
[TBL] [Abstract][Full Text] [Related]
5. Splicing and Polyadenylation of Human Papillomavirus Type 16 mRNAs.
Wu C; Kajitani N; Schwartz S
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208770
[TBL] [Abstract][Full Text] [Related]
6. Role of the DNA Damage Response in Human Papillomavirus RNA Splicing and Polyadenylation.
Nilsson K; Wu C; Schwartz S
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29895741
[TBL] [Abstract][Full Text] [Related]
7. BRCA1-BARD1 complexes are required for p53Ser-15 phosphorylation and a G1/S arrest following ionizing radiation-induced DNA damage.
Fabbro M; Savage K; Hobson K; Deans AJ; Powell SN; McArthur GA; Khanna KK
J Biol Chem; 2004 Jul; 279(30):31251-8. PubMed ID: 15159397
[TBL] [Abstract][Full Text] [Related]
8. hnRNP G prevents inclusion on the HPV16 L1 mRNAs of the central exon between splice sites SA3358 and SD3632.
Yu H; Gong L; Wu C; Nilsson K; Li-Wang X; Schwartz S
J Gen Virol; 2018 Mar; 99(3):328-343. PubMed ID: 29458523
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneous Nuclear Ribonucleoprotein A1 (hnRNP A1) and hnRNP A2 Inhibit Splicing to Human Papillomavirus 16 Splice Site SA409 through a UAG-Containing Sequence in the E7 Coding Region.
Zheng Y; Jönsson J; Hao C; Shoja Chaghervand S; Cui X; Kajitani N; Gong L; Wu C; Schwartz S
J Virol; 2020 Sep; 94(20):. PubMed ID: 32759322
[TBL] [Abstract][Full Text] [Related]
10. hnRNP G/RBMX enhances HPV16 E2 mRNA splicing through a novel splicing enhancer and inhibits production of spliced E7 oncogene mRNAs.
Hao C; Zheng Y; Jönsson J; Cui X; Yu H; Wu C; Kajitani N; Schwartz S
Nucleic Acids Res; 2022 Apr; 50(7):3867-3891. PubMed ID: 35357488
[TBL] [Abstract][Full Text] [Related]
11. DNA damage-induced BARD1 phosphorylation is critical for the inhibition of messenger RNA processing by BRCA1/BARD1 complex.
Kim HS; Li H; Cevher M; Parmelee A; Fonseca D; Kleiman FE; Lee SB
Cancer Res; 2006 May; 66(9):4561-5. PubMed ID: 16651405
[TBL] [Abstract][Full Text] [Related]
12. HPV-16 RNA processing.
Schwartz S
Front Biosci; 2008 May; 13():5880-91. PubMed ID: 18508629
[TBL] [Abstract][Full Text] [Related]
13. mRNA Processing Factor CstF-50 and Ubiquitin Escort Factor p97 Are BRCA1/BARD1 Cofactors Involved in Chromatin Remodeling during the DNA Damage Response.
Fonseca D; Baquero J; Murphy MR; Aruggoda G; Varriano S; Sapienza C; Mashadova O; Rahman S; Kleiman FE
Mol Cell Biol; 2018 Feb; 38(4):. PubMed ID: 29180510
[TBL] [Abstract][Full Text] [Related]
14. Acetylation of intragenic histones on HPV16 correlates with enhanced HPV16 gene expression.
Johansson C; Jamal Fattah T; Yu H; Nygren J; Mossberg AK; Schwartz S
Virology; 2015 Aug; 482():244-59. PubMed ID: 25900886
[TBL] [Abstract][Full Text] [Related]
15. Suppression of HPV-16 late L1 5'-splice site SD3632 by binding of hnRNP D proteins and hnRNP A2/B1 to upstream AUAGUA RNA motifs.
Li X; Johansson C; Glahder J; Mossberg AK; Schwartz S
Nucleic Acids Res; 2013 Dec; 41(22):10488-508. PubMed ID: 24013563
[TBL] [Abstract][Full Text] [Related]
16. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
17. Role of Viral Ribonucleoproteins in Human Papillomavirus Type 16 Gene Expression.
Kajitani N; Schwartz S
Viruses; 2020 Sep; 12(10):. PubMed ID: 33007936
[TBL] [Abstract][Full Text] [Related]
18. KDM6A-Mediated Expression of the Long Noncoding RNA DINO Causes TP53 Tumor Suppressor Stabilization in Human Papillomavirus 16 E7-Expressing Cells.
Sharma S; Munger K
J Virol; 2020 Jun; 94(12):. PubMed ID: 32269126
[TBL] [Abstract][Full Text] [Related]
19. Polypyrimidine tract binding protein induces human papillomavirus type 16 late gene expression by interfering with splicing inhibitory elements at the major late 5' splice site, SD3632.
Somberg M; Zhao X; Fröhlich M; Evander M; Schwartz S
J Virol; 2008 Apr; 82(7):3665-78. PubMed ID: 18216120
[TBL] [Abstract][Full Text] [Related]
20. Expression of the Long Noncoding RNA DINO in Human Papillomavirus-Positive Cervical Cancer Cells Reactivates the Dormant TP53 Tumor Suppressor through ATM/CHK2 Signaling.
Sharma S; Munger K
mBio; 2020 Jun; 11(3):. PubMed ID: 32546626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
